Prognostic Value of Combined; Cox-2, Cyclin D1 and P21 Expression in Colorectal Cancer (CRC) Patients: An Immunohistochemical Study

Journals Menu

Follow SCIRP

ISSN Print: 2164-6775
ISSN Online: 2164-6783
www.scirp.org/journal/ojpathology
E-mail: ojpathology@scirp.org

Citations h5-index & Ranking*

"Prognostic Value of Combined; Cox-2, Cyclin D1 and P21 Expression in Colorectal Cancer (CRC) Patients: An Immunohistochemical Study"
written by Amir M. Salem, Mariem A. Elfeky, Nashwa Nawar, Ahmed Z. Alattar, Omar Atef Elekiabi, Mostafa M. Elaidy,
published by Open Journal of Pathology, Vol.8 No.3, 2018

has been cited by the following article(s):

[1]	Interactions of Colorectal Cancer, Dietary Fats, and Polymorphisms of Arachidonate Lipoxygenase and Cyclooxygenase Genes: A Literature Review
	Frontiers in …, 2022

[2]	Молекулярно-генетичнi особливостi колоректальної карциноми: патоморфологічна демонстрація клінічних випадків та літературний огляд
	Morphologia …, 2021

[3]	Prognostic Value of IMP3 and Cyclin D1 Expression in Patients with Colorectal Cancer
	2021

[4]	脑胶质瘤患者的 Ki-67 与 GFAP 表达及病理学意义
	2020

[5]	Prognostic significance of E-cadherin and Cox 2 expression in Tunisian patients with colorectal mucinous adenocarcinoma
	2020

[6]	AMP‐kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway
	2019

[1]	The association of p21, inhibin, and Tob-1 expression with the clinicopathological characteristics of benign and malignant colorectal lesions Beni-Suef University Journal of Basic and Applied Sciences, 2024 DOI:10.1186/s43088-024-00471-3

[2]	Interactions of Colorectal Cancer, Dietary Fats, and Polymorphisms of Arachidonate Lipoxygenase and Cyclooxygenase Genes: A Literature Review Frontiers in Oncology, 2022 DOI:10.3389/fonc.2022.865208

[3]	Prognostic significance of E-cadherin and Cox 2 expression in Tunisian patients with colorectal mucinous adenocarcinoma Annals of Diagnostic Pathology, 2020 DOI:10.1016/j.anndiagpath.2020.151624

[4]	AMP‐kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway IUBMB Life, 2019 DOI:10.1002/iub.2136

[5]	AMP‐kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway IUBMB Life, 2019 DOI:10.1002/iub.2136

Follow SCIRP